Interestingly, in hepatocellular carcinoma (HCC) the nuclear factor erythroid 2-like 3 (NFE2L3), which has been largely involved in cancer development, induces the expression of ISG15 by binding to the antioxidant response element (ARE) located in the ISG15 promoter. Here, NFE2L3 is linked to hepatocellular carcinoma.